Investing Profile

David Kabakoff

InvestorVC
Partner at HealthQuest Capital
healthquestcapital.com/teamSan Francisco, California
Photo of David Kabakoff, Partner at HealthQuest Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$15.0M - $50.0M
$25.0M
9
$675M
CompanyStageDateRound SizeTotal Raised
RareCyte
Series GSep 2021$24M
Series FDec 2019$22M
$76M
Co-investors: Brian Daniels (5am Ventures), Robert Weisskoff (F-Prime Capital Partners), Robert Shepler (Telegraph Hill Partners), Jan Garfinkle (Arboretum Ventures)
Neurana Pharmaceuticals
Series AMay 2018$60M
$60M
Co-investors: Dan Becker (Access Biotechnology)
Dauntless Pharmaceuticals
Series AFeb 2017$25M
Series AJan 2016
Series AJul 2015$12M
$37M
Co-investors: Nina Kjellson (Canaan Partners)
NextCure
Series AJan 2016$67M
$160M
Co-investors: Colleen Cuffaro (Canaan Partners), Tim Shannon (Canaan Partners)
Lineagen
Series CJan 2015$12M
$12M
Trius Therapeutics
Series AFeb 2007$20M
$20M